ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 006,57
0,87%
Dow Jones
38 762,59
0,13%
DAX
18 575,94
0,86%
Brent Oil
78,405
1,68%
Bitcoin
71 674,24
1,49%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Synergy Pharmaceuticals, Inc. (SGYP)

  7. Synergy Pharmaceuticals, Inc. (SGYP) Actualités

SGYP

Synergy Pharmaceuticals, Inc. (SGYP)

Synergy Pharmaceuticals, Inc.
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SGYP
DateHeureSourceTitreSymboleSociété
01/12/202108h00GlobeNewswire Inc.OKYO Pharma Limited: Directorate ChangeNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
02/05/201916h58Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
02/05/201916h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
06/03/201915h30PR Newswire (US)Synergy Pharmaceuticals Announces Completion of Sale to Bausch HealthNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
06/03/201915h00PR Newswire (Canada)Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
02/03/201901h13Dow Jones NewsSynergy Pharmaceuticals Is Approved to Sell Assets to Bausch HealthNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
02/03/201900h30PR Newswire (US)Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch HealthNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
27/02/201901h07Dow Jones NewsBausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
27/02/201900h00PR Newswire (US)Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business AssetsNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/02/201918h53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
17/12/201821h43Dow Jones NewsSynergy Pharmaceuticals Up 55% on Trulance Progress in CanadaNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/12/201817h10Dow Jones NewsFormer Pharma Highflier Appreciates Bathroom Humor -- OverheardNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/12/201814h18Dow Jones NewsBausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--UpdateNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/12/201813h14Dow Jones NewsBausch Health Agrees to Buy Synergy Pharmaceuticals for $200 MillionNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/12/201812h30PR Newswire (US)Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceut...NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
12/12/201812h00PR Newswire (US)Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business AssetsNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
15/11/201818h33Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
09/11/201815h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
08/11/201823h00Business WireSynergy Pharmaceuticals Reports Third Quarter 2018 Financial Results and Business UpdateNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
31/10/201822h00Business WireSynergy Pharmaceuticals Names Dr. Melvin K. Spigelman ChairmanNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
25/10/201823h00Business WireSynergy Pharmaceuticals Provides Business UpdateNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
08/10/201814h00Business WireSynergy Pharmaceuticals Presents New Analyses Supporting the Use of TRULANCE® (plecanatide) in Two Patient Populations at th...NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
01/10/201815h30Business WireSynergy Pharmaceuticals to Present New Analyses of TRULANCE® (Plecanatide) at the American College of Gastroenterology (ACG)...NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
24/09/201814h00Business WireSynergy Pharmaceuticals Strengthens Coverage for TRULANCE® (plecanatide) with Key New Market Access WinsNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
16/08/201823h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPSynergy Pharmaceuticals, Inc.
08/08/201803h22Business WireCORRECTING and REPLACING Synergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business UpdateNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
07/08/201823h00Business WireSynergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business UpdateNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
07/08/201815h00Business WireSynergy Pharmaceuticals Announces TRULANCE® (plecanatide) Added to Express Scripts 2019 National Preferred Formulary ListNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
07/08/201812h00Business WireSynergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE® (plecanatide) in ChinaNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
13/06/201813h30Business WireSynergy Pharmaceuticals Announces Amendment to CRG Debt AgreementNASDAQ:SGYPSynergy Pharmaceuticals, Inc.
 Showing the most relevant articles for your search:NASDAQ:SGYP

Dernières Valeurs Consultées

COIN
BUUSD
BUMO
USOTC
PSTO
Powerstorm (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés